Valproate Medications, Pregnancy, and Migraine

Teri Robert @trobert Health Guide
  • The FDA is reminding health care professionals of the risk of major birth defects (MBDs) in babies exposed to one of the few medications to be FDA approved for Migraine prevention during the mother's pregnancy.


    Valproate sodium and related medications subject to this warning include:

    • divalproex sodium: Depakote, Depakote CP, Depakote ER
    • valproate sodium: Depacon
    • valproic acid: Depakene and Stavzor

    Women who take these medications during pregnancy have an increased risk of giving birth to children with neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations. In the United States, about 1 in 1,500 babies is born with a neural tube defect. The risk of neural tube defects is much higher in babies born to mothers treated with valproate during the first 12 weeks of pregnancy, with the risk increasing to 1 in 20 babies...

    Add This Infographic to Your Website or Blog With This Code:


    Learn more in our article Valproate Medications, Pregnancy, and Migraine.


    Live well,



    Follow me on    or 




    Page copy protected against web site content infringement by Copyscape© Teri Robert, 2009
    Last updated December 7, 2009


Published On: December 07, 2009